MVASI vs VELBAN

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 19, 2026·How we rate

Possible drug interaction. MVASI and VELBAN are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	MVASI	VELBAN
Rating	72/100	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	BEVACIZUMAB-AWWB	VINBLASTINE SULFATE
Manufacturer	Amgen Inc	Lilly
Dosage forms	Injectable	Injectable
Drug class	—	Vinca Alkaloid
Boxed warning	None	None
Treats	Non-Small-Cell Lung Carcinoma, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms	Breast Neoplasms, Choriocarcinoma, Head and Neck Neoplasms

mvasi velban

Rating

72/100

New

Pharmacy pays

—

Type

Active ingredient

BEVACIZUMAB-AWWB

VINBLASTINE SULFATE

Manufacturer

Amgen Inc

Lilly

Dosage forms

Injectable

Drug class

—

Vinca Alkaloid

Boxed warning

None

Treats

Non-Small-Cell Lung Carcinoma, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms

Breast Neoplasms, Choriocarcinoma, Head and Neck Neoplasms

Frequently asked questions

What is the difference between Mvasi and Velban?

Mvasi contains Bevacizumab-Awwb, while Velban contains Vinblastine Sulfate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.